Latest Breaking News On - Crinetics pharmaceuticals inc - Page 14 : comparemela.com

Crinetics: Paltusotine s Phase 3 Triumph Transforms Trajectory (Rating Upgrade) (CRNX)

Crinetics: Paltusotine s Phase 3 Triumph Transforms Trajectory (Rating Upgrade) (CRNX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Grand viewNew zealand generalNew zealandFinancial healthWellington management groupView researchCrinetics pharmaceuticals incClinical progress positions crineticsCrinetics pharmaceuticalsGrand view researchSeeking alphaDriehaus capital managementState street

Oppenheimer Raises Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $48 00

Oppenheimer Raises Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $48 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandDana pizzutiStephenf betzAnalyst recommendations for crinetics pharmaceuticalsWellington management groupInstitutional trading of crinetics pharmaceuticalsPricet rowe associates incCrinetics pharmaceuticals price performanceJennison associatesJefferies financial groupMorgan stanleyBlackrock incVanguard group incNews ratings for crinetics pharmaceuticals dailyCantor fitzgerald

Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement

Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerNatalie badilloCorey davisCrinetics pharmaceuticalsHead of corporate communicationsLifesci advisorsExchange commissionCrinetics pharmaceuticals announces oversubscribedCrinetics pharmaceuticals incHc wainwright coSecurities exchangePharmaceuticals announces oversubscribedDriehaus capital managementFirst light asset managementGlobal investments

MBB Public Markets I LLC Has $259,000 Stock Position in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX)

MBB Public Markets I LLC Has $259,000 Stock Position in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dana pizzutiStephenf betzChina universal asset management coNews ratings for crinetics pharmaceuticals dailyJpmorgan chase coMorgan stanleyOsaic holdings incCrinetics pharmaceuticalsCrinetics pharmaceuticals incRoyal bankTower research capitalCantor fitzgeraldQuarter for crinetics pharmaceuticalsCrinetics pharmaceuticals price performanceJefferies financial groupCrinetics pharmaceuticals profile

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNatalie badilloCorey davisJohnd baxterScott struthersCrinetics pharmaceuticals reports fourth quarterCrinetics pharmaceuticals incDrug administrationCrinetics pharmaceuticalsHead of corporate communicationsRadionetics oncology incLifesci advisorsSecurities exchangePharmaceuticals reports fourth quarterFull yearProvides corporate